BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

287 related articles for article (PubMed ID: 2332635)

  • 1. Temporal expression of different pathways of 1-arginine metabolism in healing wounds.
    Albina JE; Mills CD; Henry WL; Caldwell MD
    J Immunol; 1990 May; 144(10):3877-80. PubMed ID: 2332635
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nitric oxide metabolism in wounds.
    Schäffer MR; Tantry U; van Wesep RA; Barbul A
    J Surg Res; 1997 Jul; 71(1):25-31. PubMed ID: 9271274
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of arginase in rat and rabbit alveolar macrophages by N omega-hydroxy-D,L-indospicine, effects on L-arginine utilization by nitric oxide synthase.
    Hey C; Boucher JL; Vadon-Le Goff S; Ketterer G; Wessler I; Racké K
    Br J Pharmacol; 1997 Jun; 121(3):395-400. PubMed ID: 9179379
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regulation of macrophage physiology by L-arginine: role of the oxidative L-arginine deiminase pathway.
    Albina JE; Mills CD; Henry WL; Caldwell MD
    J Immunol; 1989 Dec; 143(11):3641-6. PubMed ID: 2584712
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Arginine metabolism in wounds.
    Albina JE; Mills CD; Barbul A; Thirkill CE; Henry WL; Mastrofrancesco B; Caldwell MD
    Am J Physiol; 1988 Apr; 254(4 Pt 1):E459-67. PubMed ID: 3354662
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Altered wound arginine metabolism by corticosterone and retinoic acid.
    Ulland AE; Shearer JD; Coulter C; Caldwell MD
    J Surg Res; 1997 Jun; 70(1):84-8. PubMed ID: 9228933
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nitric oxide in the healing wound: a time-course study.
    Lee RH; Efron D; Tantry U; Barbul A
    J Surg Res; 2001 Nov; 101(1):104-8. PubMed ID: 11676563
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Infected chronic wounds show different local and systemic arginine conversion compared with acute wounds.
    Debats IB; Booi D; Deutz NE; Buurman WA; Boeckx WD; van der Hulst RR
    J Surg Res; 2006 Aug; 134(2):205-14. PubMed ID: 16631201
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Upregulation of arginase expression in wound-derived fibroblasts.
    Witte MB; Barbul A; Schick MA; Vogt N; Becker HD
    J Surg Res; 2002 Jun; 105(1):35-42. PubMed ID: 12069499
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Local arginine supplementation results in sustained wound nitric oxide production and reductions in vascular endothelial growth factor expression and granulation tissue formation.
    Heffernan D; Dudley B; McNeil PL; Howdieshell TR
    J Surg Res; 2006 Jun; 133(1):46-54. PubMed ID: 16631200
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Age-related changes in arginine and its metabolites in memory-associated brain structures.
    Liu P; Jing Y; Zhang H
    Neuroscience; 2009 Dec; 164(2):611-28. PubMed ID: 19699269
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased nitric oxide formation followed by increased arginase activity induces relative lack of arginine at the wound site and alters whole nutritional status in rats almost within the early healing period.
    Zunić G; Supić G; Magić Z; Drasković B; Vasiljevska M
    Nitric Oxide; 2009 Jun; 20(4):253-8. PubMed ID: 19371593
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Arginine metabolites in wound fluids from pressure ulcers: a pilot study.
    Childress B; Stechmiller JK; Schultz GS
    Biol Res Nurs; 2008 Oct; 10(2):87-92. PubMed ID: 18829591
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Supplemental enteral arginine is metabolized to ornithine in injured patients.
    Tsuei BJ; Bernard AC; Barksdale AR; Rockich AK; Meier CF; Kearney PA
    J Surg Res; 2005 Jan; 123(1):17-24. PubMed ID: 15652946
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of ornithine as a proline precursor in healing wounds.
    Albina JE; Abate JA; Mastrofrancesco B
    J Surg Res; 1993 Jul; 55(1):97-102. PubMed ID: 8105150
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Production of citrulline and ornithine by interferon-gamma treated macrophages.
    Benninghoff B; Lehmann V; Eck HP; Dröge W
    Int Immunol; 1991 May; 3(5):413-7. PubMed ID: 1911530
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interleukin 1beta-mediated inhibition of arginase in RINm5F cells.
    Cunningham JM; Mabley JG; Green IC
    Cytokine; 1997 Aug; 9(8):570-6. PubMed ID: 9245484
    [TBL] [Abstract][Full Text] [Related]  

  • 18. L-arginine metabolism in dog kidney and isolated nephron segments.
    Levillain O; Rabier D; Duclos B; Gaudreau P; Vinay P
    Metabolism; 2008 Jan; 57(1):9-23. PubMed ID: 18078854
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Arginase release by primary hepatocytes and liver slices results in rapid conversion of arginine to urea in cell culture media.
    Peters SJ; Haagsman HP; van Norren K
    Toxicol In Vitro; 2008 Jun; 22(4):1094-8. PubMed ID: 18348903
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Macrophage arginine metabolism to ornithine/urea or nitric oxide/citrulline: a life or death issue.
    Mills CD
    Crit Rev Immunol; 2001; 21(5):399-425. PubMed ID: 11942557
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.